<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05035251</url>
  </required_header>
  <id_info>
    <org_study_id>GP_2021_KNN</org_study_id>
    <nct_id>NCT05035251</nct_id>
  </id_info>
  <brief_title>Glymphatic Pathway in Brain Imaging</brief_title>
  <official_title>Glymphatic Pathway in Brain Imaging: Evaluation of MRI Findings</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paracelsus Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Paracelsus Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the pathways of Gadolinium-based contrast agent (GBCA) in different brain&#xD;
      compartments and evaluate correlations of GBCA enhancement with specific diseases.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the contrast enhancement in different brain compartments. Until recently, it&#xD;
      had been assumed that Gadolinium-based contrast agents do not cross the blood-brain barrier,&#xD;
      but delayed imaging revealed signal increase in a number of compartments in the CSF (the&#xD;
      perilymph of the inner ear, the internal auditory canal, the Meckel's cave, the suprasellar&#xD;
      cistern, the ambient cistern and anterior eye compartment). These findings suggested, that&#xD;
      Gadolinium-based contrast agents (GBCA) penetrate into the CSF through the choroid plexus and&#xD;
      the aqueous chamber of the eye. MRI has provided the evidence of presence of meningeal&#xD;
      lymphatic vessels in human and non-human primates for central nervous system waste clearance.&#xD;
      It has been demonstrated that heavily T2-weighted fluid-attenuated inversion recovery&#xD;
      (hT2w-FLAIR) MRI detects even very low concentrations of GBCA in the CSF.&#xD;
&#xD;
      The aim of our study is to find specific enhancement patterns in various cerebral&#xD;
      compartments in correlation with specific diseases and procedures such as radiation, surgery&#xD;
      and drug application in delayed gadolinium imaging. Only patients with a clinical indication&#xD;
      for GBCA will be included in this prospective study. Before enrollment, each patient will&#xD;
      have provided written informed consent of participation and publication prior to inclusion to&#xD;
      the observational study. The scan will be performed as baseline before intravenous contrast&#xD;
      administration of a single dose of gadoteric acid 20 minutes and 120 minutes after contrast&#xD;
      administration. Whole-brain image stacks will be analyzed on patient basis. Regions of&#xD;
      interest for signal intensity measurements will be drawn in various cerebral fluid spaces,&#xD;
      the size of the region of interest will depend on the target structure. The following&#xD;
      structures should be measured: lateral and central aqueous chamber and vitreous body of the&#xD;
      eye, distal optic nerve sheath, Meckel's cave, lateral ventricles and basal cisterns.&#xD;
&#xD;
      Data will be expressed as mean values +/- one-fold standard deviation (SD). The normality of&#xD;
      data distribution will be assessed using Levene's test. Data showing a Gaussian distribution&#xD;
      will be evaluated by an analysis of variances (ANOVA) with a post-hoc analysis. Estimated&#xD;
      sample size is around 30 patients in the control and the experimental group. Cases with&#xD;
      missing or unavailable data will be excluded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 11, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Change of Signal-Intensity (SI)-Measurements with ROI in 3 specific MRI Scans</measure>
    <time_frame>Baseline (nativ scan), 20 minutes and 120 minutes after contrast media application</time_frame>
    <description>Regions of interest for signal intensity measurements will be drawn in various cerebral fluid spaces, the size of the region of interest will depend on the target structure. Following structures will be measured: lateral and central aqueous chamber and vitreous body of the eye, distal optic nerve sheath, Meckel's cave, lateral ventricles and basal cisterns.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Glymphatic System</condition>
  <arm_group>
    <arm_group_label>experimental</arm_group_label>
    <description>patients with a condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>patients without condition</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be patients of a primary care clinic.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Only patients with a clinical indication for GBCA&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
          -  No allergies to GBCA&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications for MRI&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Radiology and Nuclear Medicine</name>
      <address>
        <city>Nuremberg</city>
        <state>Bavaria</state>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Panagiota Manava, Dr.</last_name>
      <phone>+49 911 398 114930</phone>
      <email>panagiota.manava@klinikum-nuernberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael M. Lell, Prof. Dr.</last_name>
      <phone>+49 911 398 2540</phone>
      <email>michael.lell@klinikum-nuernberg.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Deike-Hofmann K, Reuter J, Haase R, Paech D, Gnirs R, Bickelhaupt S, Forsting M, Heußel CP, Schlemmer HP, Radbruch A. Glymphatic Pathway of Gadolinium-Based Contrast Agents Through the Brain: Overlooked and Misinterpreted. Invest Radiol. 2019 Apr;54(4):229-237. doi: 10.1097/RLI.0000000000000533.</citation>
    <PMID>30480554</PMID>
  </reference>
  <reference>
    <citation>Taoka T, Naganawa S. Gadolinium-based Contrast Media, Cerebrospinal Fluid and the Glymphatic System: Possible Mechanisms for the Deposition of Gadolinium in the Brain. Magn Reson Med Sci. 2018 Apr 10;17(2):111-119. doi: 10.2463/mrms.rev.2017-0116. Epub 2018 Jan 25.</citation>
    <PMID>29367513</PMID>
  </reference>
  <reference>
    <citation>Absinta M, Ha SK, Nair G, Sati P, Luciano NJ, Palisoc M, Louveau A, Zaghloul KA, Pittaluga S, Kipnis J, Reich DS. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife. 2017 Oct 3;6. pii: e29738. doi: 10.7554/eLife.29738.</citation>
    <PMID>28971799</PMID>
  </reference>
  <reference>
    <citation>Rennels ML, Gregory TF, Blaumanis OR, Fujimoto K, Grady PA. Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 1985 Feb 4;326(1):47-63.</citation>
    <PMID>3971148</PMID>
  </reference>
  <reference>
    <citation>Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012 Aug 15;4(147):147ra111. doi: 10.1126/scitranslmed.3003748.</citation>
    <PMID>22896675</PMID>
  </reference>
  <reference>
    <citation>Bedussi B, Almasian M, de Vos J, VanBavel E, Bakker EN. Paravascular spaces at the brain surface: Low resistance pathways for cerebrospinal fluid flow. J Cereb Blood Flow Metab. 2018 Apr;38(4):719-726. doi: 10.1177/0271678X17737984. Epub 2017 Oct 17. Erratum in: J Cereb Blood Flow Metab. 2018 Apr;38(4):746.</citation>
    <PMID>29039724</PMID>
  </reference>
  <reference>
    <citation>Smith AJ, Yao X, Dix JA, Jin BJ, Verkman AS. Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. Elife. 2017 Aug 21;6. pii: e27679. doi: 10.7554/eLife.27679.</citation>
    <PMID>28826498</PMID>
  </reference>
  <reference>
    <citation>Dobson H, Sharp MM, Cumpsty R, Criswell TP, Wellman T, Finucane C, Sullivan JM, Weller RO, Verma A, Carare RO. The perivascular pathways for influx of cerebrospinal fluid are most efficient in the midbrain. Clin Sci (Lond). 2017 Nov 13;131(22):2745-2752. doi: 10.1042/CS20171265. Print 2017 Nov 15.</citation>
    <PMID>29021222</PMID>
  </reference>
  <reference>
    <citation>Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A, Plog BA, Liao Y, Deane R, Nedergaard M. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci. 2013 Nov 13;33(46):18190-9. doi: 10.1523/JNEUROSCI.1592-13.2013.</citation>
    <PMID>24227727</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 25, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Paracelsus Medical University</investigator_affiliation>
    <investigator_full_name>Dr. Panagiota Manava</investigator_full_name>
    <investigator_title>Senior physician, Institute of Radiology and Nuclear Medicine, Klinikum Nuernberg</investigator_title>
  </responsible_party>
  <keyword>glymphatic system</keyword>
  <keyword>imaging of blood brain barrier</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

